Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Markers of Breast Cancer Prevention Induced by HCG in Women at High Risk

NCT00700778 is registered in ClinicalTrials.gov with Fox Chase Cancer Center as lead sponsor.

NCT NCT00700778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00700778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Markers of Breast Cancer Prevention Induced by HCG in Women at High Risk
Lead sponsor
Fox Chase Cancer Center
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2008
Completion date
March 31, 2014
Enrollment
2 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, breast cancer